MYH7 gene mutations are associated with wide clinical and genetic heterogeneity. We report a novel founder mutation in MYH7 in Southern Spain (Andalucía). We studied two index patients and 24 family members from two apparently independent families by physical examination, serum creatine-kinase, muscle MRI, sequencing studies and genetic linkage analysis. Sixteen individuals were heterozygous for a (p.R1560P) variant in the MYH7 gene. Haplotype was consistent with a common ancestor for the two families. The patients displayed the classic Laing distal myopathy phenotype, with hanging first toe as the initial presentation, even in mildly affected patients who declared themselves asymptomatic, although neck flexor weakness was revealed as an early sign in some cases.
M A N U S C R I P T INTRODUCTION
Laing distal myopathy is an autosomal dominant disease, commonly characterized by slowly progressive distal weakness, involving the anterior compartment of the legs, thus causing the typical "hanging big toe" sign [1] . Nevertheless, highly variable clinical and histological phenotypes have been widely reported in Laing distal myopathy [2] [3] [4] , and the ACCEPTED MANUSCRIPT A C C E P T E D M A N U S C R I P T 4 same mutation in the MYH7 gene can cause a different clinical picture regarding age of onset, weakness pattern or severity and variable pathologic profiles, even within the same family [3] .
Concerning muscle MRI in the Laing distal myopathy, the tibialis anterior is the earliest and more severely affected muscle in all the reported cases. To date, several case reports [3, 5, 6] and one study with detailed analysis on radiological pattern in a cohort of Laing distal myopathy patients [7] have been published, reporting quite variable and not always consistent conclusions regarding the muscle imaging findings other than the tibialis anterior early involvement.
The largest series of distal myopathy patients with mutations in MYH7 reported a high rate of de novo mutations. This high frequency of sporadic mutations suggest that there should be a wide geographical distribution [7] [8] [9] . Exceptionally, a founder mutation in the MYH7 gene, p.K1729del has been found to cause the majority of Laing distal myopathy cases in the Safor region, Spain [10] . Most mutations are associated with the classic phenotype of Laing distal myopathy. However, in the series reported by Fiorillo et al [7] some atypical clinical features were reported which delayed the diagnosis.
Lamont et al reported eight out of 15 families with missense mutations introducing a proline in MYH7 associated with distal myopathy [9] . These mutations involve aminoacid residues at all positions of the heptad repeat of the protein which would induce significant modifications in the protein structure, which suggests that proline substitutions at any of these positions has a pathogenic effect [11, 12] .
Here, we report a novel mutation in the MYH7 gene with a founder effect in Andalucía (South of Spain). The description of founder mutations and the analysis of a potential genotype-phenotype correlation are important from a diagnostic point of view, especially when variable phenotypical expression is associated with the disease.
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METHODS

Patients and study protocol
We initially identified two apparently unrelated patients with a distal anterior myopathy, both from Andalucía (Fig. 1 ). Patient II.6/Family A reported several affected relatives including his father and at least four siblings. Patient II.3/Family B was a sporadic case.
Affected and unaffected relatives from both families were contacted and offered the possibility of participating in the study. The participants were examined using a standardized protocol which included interview, physical exam, muscle MRI, serum CK and blood sample to obtain DNA. The first step of the clinical protocol was the interview of the recruited family members to collect the clinical data and classify them as symptomatic or asymptomatic, followed by a complete general and neurological examination, including manual muscle testing, and the rest of the tests. This study received approval from the HUVR local Ethics Committee and all participants provided informed consent. Immunohistochemistry for fast and slow myosin was performed in one case.
Muscle biopsy
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Muscle MRI
Muscle MRI was performed at the level of the thighs and lower legs. We used a 1.5 Tesla scanner (MRI Intera, Philips Medical Systems). Axial MRI sections were obtained including a T1-weighted spin-echo sequence (TR 600-700 ms, TE 30 ms) and a short-time inversion recovery (STIR) sequence (TR 2500-3500 ms, TE 60 ms, TI 150 ms), in 10 mm slices. Fatty degeneration of muscles was identified according to the increased signal in T1 sequences and quantified according to a subjective scale [13] , and STIR sequences were used to evaluate the presence of edema.
MYH7 genetic study
Genomic DNA was extracted as per standard protocols from peripheral blood (Chemagic 
Haplotype analysis
Microsatellite and SNP markers covering the MYH7 gene were selected based on their genomic location and heterozygosity (UCSC Genome Browser, Human GRCh37/hg19; http://genome.ucsc.edu/) [14] . They spanned a genomic region of 2,92 Mb. Microsatellite markers were amplified by PCR using fluorescently-labelled primers and resolved in an ABI 3500 Genetic Analyzer (Applied Biosystems). SNP loci were PCR-amplified and genotypes were determined by visual inspection of the sequence chromatograms.
Haplotypes were built assuming the minimum number of recombinations.
RESULTS
Clinical phenotype
We performed the interview and physical examination in 23 individuals from the two Table 1 and Figure 2 .
Muscle histology
Muscle biopsies from four patients (II.5/Family A, II.6/Family A, II.14/Family A, II.3/Family B), two tibialis anterior and two gastrocnemius muscles, were available for review. Myopathic pattern with increased variability in fiber size and internal nuclei were present in all biopsies. More severe changes with prominent atrophy and increased endomysial connective tissue were observed in both tibialis anterior muscles ( Fig 3A and   3B ). Small group of angulated fibers and nuclear clumps suggesting neurogenic features were seen in three of the four samples ( Fig 3A and 3F ). Oxidative enzyme stains (NADH, SDH and COX) revealed prominent internal sarcoplasmic disorganization with core, core with poor defined bordersand minicore lesions in all biopsies ( Fig 3C and 3G ). We observed type I fiber predominance in three cases ( Fig 3D) and scattered rimmed vacuoles in one case. No hypotrophy of type I fibers was observed.
Imaging study
Muscle MRI was performed in 11 patients ( Table 2 and Figure 4 .
MYH7 mutation screening
The novel heterozygous mutation c.4679G>C (NG_007884.1) p.R1560P in exon 34 of MYH7 was identified in both index patients (Fig. 1) . 
Haplotype analysis
Given the identification of the same novel mutation in two families from different cities in Andalucía, Southern Spain, we studied the possibility of them being related. Haplotype analysis revealed a shared genomic region of 306 Kb in all carriers of p.R1560P mutation, restricted to four SNP markers ( Fig 5) .
DISCUSSION
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The shared haplotype identified in our study spans a short genomic region (306 Kb) defined by SNP markers, however, the data are in accordance with the findings by Muelas et al. [10] , that show a common SNP-defined genomic region of 41,2-71,2 Kb. In our Neuromuscular Unit at HUVR, which is a national reference unit, only patients with ancestors from Southern Spain carry the novel c.4679G>C (p.R1560P) mutation in MYH7, while in patients from other geographic regions of Spain the disease is due to different mutations, all of them already described. Thus, this mutation should be the first mutation to study in patients with this disease phenotype from Southern Spain. Proline residues are widely known to have a pathogenic effect on the assembly of the protein [15, 16] .
Moreover, most mutations in MYH7 associated with distal myopathy are located in the mid-rod region of MYH7 protein encoded by exons 32 to 36 [17, 18] . All together, these findings support the pathogenic role of this novel mutation. The high rate of de novo mutations demonstrated in MYH7 together with the long lifespan of patients with Laing distal myopathy could explain the high prevalence of cases, regardless of geographic or ethnic distribution [7, 9] . Hence, the identification of founder mutations in specific geographic areas facilitates the molecular diagnosis of patients.
A noticeable clinical and genetic heterogeneity is associated with the MYH7-related myopathies [3, 4, 9] . Until now, only one founder mutation in MYH7 has been reported, and it was also associated with a wide range of clinical and morphologic features among the carriers [3, 10] . In this study, we identified the clinical variability previously reported in other series, finding patients severely or mildly affected at a similar age, in the same family. Four previously reported large series of patients showed that age at onset varied between 0 and 50 years [3, 7, 9, 19] and in our series the onset was between four and 30 years of age (none of the patients with congenital onset), and the asymptomatic ones later onset presented prevalent proximal weakness [7] . In contrast, in our series with a novel mutation affecting the rod domain we found no differences in the distribution of the weakness related to the age of onset. In our cohort, we found three asymptomatic carriers (age ranged 11-38 years old) and five slightly affected patients (age ranged 8-42 years old).
Tasca et al. reported one family carrying a novel mutation in the myosin tail, and the age of onset of all three affected members was not prior the fifth decade and shared mild weakness limited to long toe and foot extensors [4] . Feinstein-Linial et al., who reported two novel heterozygous proline substitutions located in exon 31 of MYH7, described also one asymptomatic carrier aged 40 [5] . This confirms that more benign forms than the classic phenotype exist, probably associated with better prognosis regarding the progression of the disease.
We uncovered interesting manifestations after a thorough anamnesis and clinical exam.
The majority of carriers of the mutation reported abnormal gait with increasing tendency to stumble and fall in infancy or childhood, although most of them did not complain of motility or muscle problems until the third or fourth decade, a finding also described by Muelas et al [3] . A review of 34 patients with Laing distal myopathy by Lamont et al.
revealed that initial weakness of great toe/ankle dorsiflexion and later development of neck flexor weakness were consistent findings [9] . Interestingly, two infantile carriers in our series presented neck flexor weakness only during childhood. Recently, one atypical case with dropped head at the age of four has been reported, but authors do not refer if it disappeared later and revealed also calf hypertrophy and cardiopathy at the age of eight [7] . Thus, we must be attentive to abnormal gait or cervical weakness during infancy
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12 because it can be the first transient symptom or sign of the disease. Hanging big toe is the typical sign of this disease, it is frequently the first obvious sign [4] , even we uncovered hanging big toe in three mildly affected patients who self-reported no symptoms, as already reported by Muelas et al. in two patients [3] . However, we observed no correlation between the severity of the toe extensor weakness and the severity of other manifestations.
Thus, weakness of the big toe extension may represent the most consistent clinical sign in every stage of the disease, although neck flexor weakness and abnormal gait during infancy could represent the first manifestation in some cases. Calf hypertrophy and pes cavus are findings reported in other families [3, 4] , and we found these symptoms only in family A, so they do not seem to be specific to the novel mutation c.4679G>C.
Regarding the muscle biopsy, our series also showed some of the variable morphological findings previously reported: hypotrophy of type I fibers, fiber type disproportion, areas devoid of oxidative activity forming cores/pseudocores, angulated fibers, nuclear clumps, and rimmed vacuoles [3, 9, 19] . However, which is the most prominent morphological feature varies between series, thus atrophic type I fiber was found as the most common abnormality in some previous series but it was not observed in our study, while cores/pseudocores were highly frequent in most of the series [3, 9] and ours but were not described by Lamont et al [19] .
We have reviewed the MRI descriptions reported until now, demonstrating variability in radiological findings [3, 4, 6, 7] . As previously described, in our series the tibialis anterior muscle becomes the most severely degenerated muscle in early stages of the disease, and the gastrocnemius medialis muscle was simultaneously affected in one patient which is in accordance with recent reports showing involvement of the gastrocnemius medialis in about half of the patients [5] [6] [7] [8] . However, some authors described that the gastrocnemius together with the gracilis and the sartorius muscles are usually preserved even in severely affected patients [3, 20] , and our data contradict this assertion. We observed that the involvement of the sartorius muscle is a very early radiological finding in our patients, even in presymptomatic stages. This is quite surprising, since the sartorious muscle is usually preserved until late stages in many other neuromuscular disorders, except for some myofibrillar myopathies where it seems to be a hallmark [21] . The involvement of the adductor magnus and the sartorius muscles has only been mentioned in few reports of Laing distal myopathy, with no further analysis regarding their evolution [5, 7] . We observed that the degree of involvement of the sartorius is always mild at early stages,
showing no further progression of the degeneration during the course of the disease.
Although this has not been described as a typical radiological sign in Laing distal myopathy, our results support that the mild involvement of the sartorius muscle is a common and early radiological sign in this myopathy, prior to the involvement of the tibialis anterior muscle, even in asymptomatic carriers, so it could be a useful sign for screening.
To conclude, our findings support the novel variant p.R1560P in MYH7 as a founder mutation in Andalucía, and it should be considered the first mutation to study in patients from Southern Spain. These large pedigrees allowed us to better describe the progression and diagnostic clues in very early stages of the disease, such as neck flexor weakness, hanging big toe and the sartorius muscle degeneration in muscle MRI, which could be useful for detecting asymptomatic carriers of the MYH7 mutation. All these findings are important to improve the diagnosis and the genetic counseling of Laing distal myopathy.
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